Fangzhou (HKG:6086) has appointed Wang Haijiao as chief executive officer with effect from Thursday, according to a same-day Hong Kong bourse filing.
Shares of the online chronic disease management platform gained over 6% in Friday afternoon trade.
Wang has nearly 20 years of experience in healthcare investment and management, most recently serving as deputy general manager and executive partner at GTJA Investment Group, the filing said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments